| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |